Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy...
-
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation
-
MUNSTER, Ind., April 01, 2024 (GLOBE NEWSWIRE) -- NorthShore Health Centers, a leading provider of comprehensive, affordable healthcare, is expanding into four new communities, marking a significant...
-
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
-
Company progresses the development of furmonertinib with a data readout planned for 2024Furmonertinib granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration Completed $201...
-
JASPER, Ind., March 28, 2024 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (Nasdaq: GABC) announced today that Mary Moorhouse has been appointed Senior Vice President, Chief Risk Officer,...
-
JASPER, Ind., March 27, 2024 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (Nasdaq: GABC) has earned the number 27 spot out of 200 U.S. community banks assessed by S&P Global Market...
-
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
-
REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy...